|
||||||||||||||||||||||||||||||
 |
The Speakers
In the Chair: Mark Horn, Director, Finance & Portfolio Management, WYETH CONSUMER HEALTHCARE
Markus Thunecke |
Senior Partner |
CATENION |
 |
||
Pasi Piitulainen |
Director, Global Clinical Development Affairs |
ACTELION |
|
||
Roger Holdsworth |
Associated Director, Portfolio Analysis |
UCB |
|
||
Allan Wehnert |
Vice President, Corporate Project Management R&D |
H.LUNDBECK |
|
||
Eric Rambeaux |
Vice President, Business Strategy and Portfolio |
SOLVAY |
|
||
Bernd Seilheimer |
Head, Global R&D Risk Management |
BAYER SCHERING PHARMA AG |
|
||
Kerstin Bode-Greuel |
Associate Lecturer |
UNIVERSITY OF ESSEN |
|
||
David Rosen |
Development and Commercial Head, StrategicAlliances |
PFIZER |
|
||
Andre Hoekema |
Senior Vice President, Corporate Development | GALAPAGOS |
|
||
Tony Ellery |
Global Head, Project Management, General Medicine Specialities and Mature Product Business Franchise |
NOVARTIS PHARMA |
|
||
| Rafaat Rahmani | Founder and President | LIFESCIENCE DYNAMICS |
|
||
| Manuel Carmona | European Sales Manager | PALISADE-EUROPE UK Ltd |
|
||
| Kimber Hardy | Senior Director, Portfolio Management | MERCK SERONO |
|
||
